|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.65 CHF | -0.07% |
|
-0.65% | +5.36% |
| Oct. 25 | GALENICA : Multiple positives in a strong Q3 24 update |  |
| Oct. 24 | Busy Earnings Day Boosts Swiss Stocks | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site
| Capitalization | 3.82B 4.33B 4.11B 3.41B 6.07B 366B 6.65B 47.29B 17.61B 150B 16.27B 15.91B 652B | P/E ratio 2024 * |
22.5x | P/E ratio 2025 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise value | 4.39B 4.98B 4.72B 3.92B 6.98B 421B 7.65B 54.39B 20.25B 173B 18.71B 18.3B 750B | EV / Sales 2024 * |
1.13x | EV / Sales 2025 * | 1.08x |
| Free-Float |
99.44% | Yield 2024 * |
2.95% | Yield 2025 * | 3.1% |
More valuation ratios
* Estimated data
More news
Last Transcript: Galenica AG
More recommendations
More press releases
More news
| 1 day | -0.07% | ||
| 1 week | -0.65% | ||
| 1 month | +1.93% | ||
| 3 months | +4.07% | ||
| 6 months | +2.61% | ||
| Current year | +5.36% |
1 week
75.90
77.30
1 month
74.5077.30
Current year
69.3078.15
1 year
69.3078.15
3 years
60.5582.20
5 years
57.1582.20
10 years
41.8082.20
| Director | Title | Age | Since |
|---|---|---|---|
Marc Werner
CEO | Chief Executive Officer | 57 | 2020-03-31 |
| Director of Finance/CFO | 58 | 2009-12-31 | |
Lukas Ackermann
CTO | Chief Tech/Sci/R&D Officer | 52 | 2021-12-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 2016-12-31 | |
Bertrand Jungo
BRD | Director/Board Member | 59 | 2017-12-31 |
| Chairman | 66 | 2023-05-02 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.18% | 5 M€ | -.--% | - | |
| 0.17% | 1,005 M€ | +9.19% | ||
| 0.02% | 10 M€ | -3.35% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.07% | -0.65% | +5.51% | +21.47% | 4.33B | ||
| +0.34% | +0.85% | +33.56% | +189.95% | 79.78B | ||
| -0.32% | +0.33% | +14.16% | +164.42% | 29.58B | ||
| -0.32% | +0.23% | +21.10% | +18.21% | 9.9B | ||
| +6.79% | +11.02% | -4.44% | +15.02% | 9.42B | ||
| +1.00% | +1.25% | +4.75% | +19.83% | 8.14B | ||
| +0.09% | -2.83% | +34.56% | - | 5.96B | ||
| -.--% | +1.33% | +2.70% | +4.25% | 4.37B | ||
| +1.70% | +2.68% | -7.76% | +5.71% | 3.64B | ||
| +0.09% | -2.26% | +11.98% | +10.78% | 3.56B | ||
| Average | +0.93% | +1.62% | +11.61% | +49.96% | 15.87B | |
| Weighted average by Cap. | +0.59% | +1.53% | +22.42% | +135.35% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 3.89B 4.41B 4.18B 3.47B 6.18B 373B 6.77B 48.16B 17.93B 153B 16.57B 16.2B 664B | 4.06B 4.6B 4.36B 3.62B 6.45B 389B 7.07B 50.25B 18.71B 160B 17.29B 16.91B 693B |
| Net income | 172M 196M 185M 154M 274M 16.54B 300M 2.13B 795M 6.78B 735M 718M 29.43B | 180M 205M 194M 161M 287M 17.31B 314M 2.23B 832M 7.1B 769M 752M 30.8B |
| Net Debt | 573M 650M 616M 511M 910M 54.95B 998M 7.09B 2.64B 22.54B 2.44B 2.39B 97.78B | 547M 621M 588M 489M 870M 52.5B 953M 6.78B 2.52B 21.54B 2.33B 2.28B 93.43B |
More financial data
* Estimated data
Employees
7,955
Sector
Pharmaceuticals
Calendar
2025-01-20
- Q4 2024 Sales and Revenue Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-11-29 | 76.65 CHF | -0.07% | 99,425 |
| 24-11-28 | 76.70 CHF | -0.58% | 45,980 |
| 24-11-27 | 77.15 CHF | +0.85% | 77,087 |
| 24-11-26 | 76.50 CHF | -0.46% | 58,928 |
| 24-11-25 | 76.85 CHF | -0.39% | 134,278 |
Delayed Quote Swiss Exchange, November 29, 2024 at 11:30 am EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
76.65CHF
Average target price
76.88CHF
Spread / Average Target
+0.29%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GALE Stock